KALA BIO, Inc. fell 13.7% on Friday, November 13, 2026, on 935,000 shares, 18 times its average daily volume. The headline around the move:
KALA BIO, Inc. (KALA:NASDAQ) closed at $3.83 on November 16, 2026, down 8.02% on the day. The stock trades 99.9% below its 52-week high of $2,865.00 and 11.4% above its 52-week low of $3.44. Over the past year, it lost 89.0%. KALA BIO, Inc. is part of the Health Care sector (Major Pharmaceuticals).
In 251 trading sessions since November 14, 2025, KALA closed higher on 95 days (38%). Its best day was November 26, 2025 (+42.63%) and its worst was May 7, 2026 (-27.83%). The stock moved 10% or more in a single session 49 times. It opened at least 5% above the previous day's high 6 times.
Kala Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary nanoparticle-based Mucus Penetrating Particles technology, with focus on the treatment of eye diseases.
Find more stocks like KALA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.